|
[1]
|
Faiz, A.S., Khan, I., Beckman, M.G., et al. (2015) Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thrombosis Research, 136, 535-541. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Blom, J.W., Doggen, C.J.M., Osanto, S. and Rosendaal, F.R. (2005) Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis. JAMA, 293, 715-722. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lyman, G.H., Culakova, E., Poniewierski, M.S. and Kuderer, N.M. (2018) Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer. Thrombosis Research, 164, S112-S118. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Reitsma, P.H., Versteeg, H.H. and Middeldorp, S. (2012) Mechanistic View of Risk Factors for Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 563-568. [Google Scholar] [CrossRef]
|
|
[5]
|
张尤磊, 王道荣, 汤东. 胃癌围手术期静脉血栓形成机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2019, 13(5): 534-536.
|
|
[6]
|
Nasser, N.J., Fox, J. and Agbarya, A. (2020) Potential Mechanisms of Cancer-Related Hypercoagulability. Cancers, 12, Article No. 566. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Horsted, F., West, J. and Grainge, M.J. (2012) Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis. PLOS Medicine, 9, e1001275. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mahajan, A., Brunson, A., White, R. and Wun, T. (2019) The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update. Seminars in Thrombosis and Hemostasis, 45, 321-325. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Blom, J.W., Osanto, S. and Rosendaal, F.R. (2004) The Risk of a Venous Thrombotic Event in Lung Cancer Patients: Higher Risk for Adenocarcinoma Than Squamous Cell Carcinoma. Journal of Thrombosis and Haemostasis: JTH, 2, 1760-1765. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Cohen, A.T., Katholing, A., Rietbrock, S., Bamber, L. and Martinez, C. (2017) Epidemiology of First and Recurrent Venous Thromboembolism in Patients with Active Cancer: A Population-Based Cohort Study. Thrombosis and Haemostasis, 117, 57-65. [Google Scholar] [CrossRef]
|
|
[11]
|
Martinez, C., Cohen, A.T., Bamber, L. and Rietbrock, S. (2014) Epi-demiology of First and Recurrent Venous Thromboembolism: A Population-Based Cohort Study in Patients without Ac-tive Cancer. Thrombosis and Haemostasis, 112, 255-263. [Google Scholar] [CrossRef]
|
|
[12]
|
Overvad, T.F., Ording, A.G., Nielsen, P.B., et al. (2022) Validation of the Khorana Score for Predicting Venous Thromboembo-lism in 40 218 Patients with Cancer Initiating Chemotherapy. Blood Advances, 6, 2967-2976. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Blom, J.W., Vanderschoot, J.P.M., Oostindiër, M.J., et al. (2006) Incidence of Venous Thrombosis in a Large Cohort of 66,329 Cancer Patients: Results of a Record Linkage Study. Journal of Thrombosis and Haemostasis: JTH, 4, 529-535. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Fotopoulou, C., DuBois, A., Karavas, A.N., et al. (2008) Incidence of Venous Thromboembolism in Patients with Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Journal of Clinical Oncology, 26, 2683-2689. [Google Scholar] [CrossRef]
|
|
[15]
|
Chavan, D.M., Huang, Z., Song, K., et al. (2017) Incidence of Venous Thromboembolism Following the Neoadjuvant Chemotherapy Regimen for Epithelial Type of Ovarian Cancer. Medicine, 96, e7935. [Google Scholar] [CrossRef]
|
|
[16]
|
Fotopoulou, C., Karavas, A., Trappe, R., et al. (2009) Ve-nous Thromboembolism in Recurrent Ovarian Cancer-Patients: A Systematic Evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO). Thrombosis Research, 124, 531-535. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liu, Y., Gao, Y., Wei, L., et al. (2015) Peripherally Inserted Central Catheter Thrombosis Incidence and Risk Factors in Cancer Patients: A Double-Center Prospective Investigation. Therapeutics and Clinical Risk Management, 11, 153-160. [Google Scholar] [CrossRef]
|
|
[18]
|
Kang, J.R., Long, L.H., Yan, S.W., et al. (2017) Peripherally Inserted Central Catheter-Related Vein Thrombosis in Patients with Lung Cancer. Clinical and Applied Thrombosis/Hemostasis, 23, 181-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Bistervels, I.M., Scheres, L.J.J., Hamulyák, E.N. and Middeldorp, S. (2019) Sex Matters: Practice 5P’s When Treating Young Women with Venous Thromboembolism. Journal of Thrombosis and Haemostasis: JTH, 17, 1417-1429. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Palareti, G., Legnani, C., Antonucci, E., et al. (2020) D-Dimer Testing, with Gender-Specific Cutoff Levels, Is of Value to Assess the Individual Risk of Venous Thromboembolic Recurrence in Non-Elderly Patients of Both Genders: A Post Hoc Analysis of the DULCIS Study. Internal and Emergency Medicine, 15, 453-462. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Hotoleanu, C. (2020) Association between Obesity and Venous Thromboembolism. Medicine and Pharmacy Reports, 93, 162-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
White, R.H. (2003) The Epidemiology of Venous Thromboembolism. Circulation, 107, I-4-I-8. [Google Scholar] [CrossRef]
|
|
[23]
|
Zöller, B., Li, X., Ohlsson, H., et al. (2015) Family History of Venous Thromboembolism as a Risk Factor and Genetic Research Tool. Thrombosis and Haemostasis, 114, 890-900. [Google Scholar] [CrossRef]
|
|
[24]
|
Zöller, B., Li, X., Sundquist, J. and Sundquist, K. (2011) Age- and Gender-Specific Familial Risks for Venous Thromboembolism: A Nationwide Epidemiological Study Based on Hospitalizations in Sweden. Circulation, 124, 1012-1020. [Google Scholar] [CrossRef]
|
|
[25]
|
Entezari-Maleki, T., Hajhossein Talasaz, A., Salarifar, M., et al. (2014) Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-Selectin and hs-CRP Level in Patients with Venous Thromboembolism; The First Study of Iranian Population. Iranian Journal of Pharmaceutical Research: IJPR, 13, 319-327.
|
|
[26]
|
曲洪雪, 刘云鹏. 骨科深静脉血栓形成危险因素及发病机制的研究进展[J]. 中国矫形外科杂志, 2009, 17(2): 110-112.
|
|
[27]
|
姚杰, 孟尽海, 王文娟, 等. 骨科手术病人术后下肢深静脉血栓形成的危险因素[J]. 中华麻醉学杂志, 2013, 33(4): 413-416.
|
|
[28]
|
Kearon, C., Spencer, F.A., O’Keeffe, D., et al. (2015) D-Dimer Testing to Select Patients with a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. Annals of Internal Medicine, 162, 27-34. [Google Scholar] [CrossRef]
|
|
[29]
|
Wang, J., Tacey, M. and Ho, P. (2020) Retrospective Review of D-Dimer Testing for Venous Thrombosis Recurrence Risk Stratification: Is This a Useful Test in the Real World? Journal of Thrombosis and Thrombolysis, 49, 562-571. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Antonopoulos, C.N., Sfyroeras, G.S., Kakisis, J.D., Moulakakis, K.G. and Liapis, C.D. (2014) The Role of Soluble P Selectin in the Diagnosis of Venous Thromboembolism. Throm-bosis Research, 133, 17-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kollias, A., Kyriakoulis, K.G., Lagou, S., et al. (2021) Venous Thromboembolism in COVID-19: A Systematic Review and Meta-Analysis. Vascular Medicine, 26, 415-425. [Google Scholar] [CrossRef]
|
|
[32]
|
Liu, Y., Cai, J., Wang, C., Jin, J. and Qu, L. (2021) A Systematic Review and Meta-Analysis of Incidence, Prognosis, and Laboratory Indicators of Venous Thromboembolism in Hospi-talized Patients with Coronavirus Disease 2019. Journal of Vascular Surgery. Venous and Lymphatic Disorders, 9, 1099-1111. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Caprini, J.A. (2010) Risk Assessment as a Guide to Thrombosis Prophylaxis. Current Opinion in Pulmonary Medicine, 16, 448-452. [Google Scholar] [CrossRef]
|
|
[34]
|
Cronin, M., Dengler, N., Krauss, E.S., et al. (2019) Com-pletion of the Updated Caprini Risk Assessment Model (2013 version). Clinical and Applied Thrombosis/Hemostasis, 25, Article ID: 1076029619838052. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Spyropoulos, A.C., Anderson, F.A., FitzGerald, G., et al. (2011) Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE. CHEST, 140, 706-714. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Al-Ogaili, A., Fuentes, H.E., Tafur, A.J. and Caprini, J. (2018) Risk Assessment as a Guide for the Prevention of Cancer-Associated Thromboembolism. International Angiology, 37, 269-276.
|
|
[37]
|
徐留海, 曾勇, 黄卫, 等. 基于Caprini血栓风险模型评估膝关节镜手术患者深静脉血栓形成的风险性[J]. 中国组织工程研究, 2016, 20(17): 2474-2480.
|
|
[38]
|
Kahn, S.R., Lim, W., Dunn, A.S., et al. (2012) Preven-tion of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST, 141, e195S-e226S. https://pubmed.ncbi.nlm.nih.gov/22315261/ [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H. and Francis, C.W. (2008) Development and Validation of a Predictive Model for Chemotherapy-Associated Thrombosis. Blood, 111, 4902-4907. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Frere, C., Wahl, C., Rueda-Camino, J.A., et al. (2022) A Re-view of Latest Clinical Practice Guidelines for the Management of Cancer-Associated Thrombosis. Best Practice & Re-search Clinical Haematology, 35, Article ID: 101348. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Streiff, M. B., Holmstrom, B., Angelini, D., et al. (2021) Can-cer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 19, 1181-1201.
|
|
[42]
|
Key, N.S., Khorana, A.A., Kuderer, N.M., et al. (2020) Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Prac-tice Guideline Update. Journal of Clinical Oncology, 38, 496-520. [Google Scholar] [CrossRef]
|
|
[43]
|
Mulder, F.I., Candeloro, M., Kamphuisen, P.W., et al. (2019) The Khorana Score for Prediction of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis. Haematologica, 104, 1277-1287. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Dapkevičiūtė, A., Daškevičiūtė, A., Zablockis, R., et al. (2020) Association between the Khorana Score and Pulmonary Embolism Risk in Patients with Advanced Stage Lung Cancer. The Clinical Respiratory Journal, 14, 3-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Barbar, S., Noventa, F., Rossetto, V., et al. (2010) A Risk Assessment Model for the Identification of Hospitalized Medical Patients at Risk for Venous Thromboembolism: The Padua Predic-tion Score. Journal of Thrombosis and Haemostasis: JTH, 8, 2450-2457. [Google Scholar] [CrossRef] [PubMed]
|